Recruiting
Phase 3

Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis

Sponsor:

United Therapeutics

Code:

NCT04708782

Conditions

Idiopathic Pulmonary Fibrosis

Interstitial Lung Disease

Eligibility Criteria

Sex: All

Age: 40+

Healthy Volunteers: Not accepted

Interventions

Placebo

Inhaled Treprostinil

Treprostinil Ultrasonic Nebulizer

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information